Additionally, this symptom is not found in medical literature about the medication or in clinical trials
Another clinical trial is currently in the works on this topic, which is testing the effects of benfotiamine on diabetic neuropathy in people with type 2 diabetes
They evaluated cohorts of 36,082 patients with type 2 diabetes using GLP-1 receptor agonists and 234,028 DPP-4 inhibitor users
More importantly, the hazard ratio for major adverse cardiovascular events (including cardiovascular death, myocardial infarction, stroke, or hospitalization for unstable angina) for the pooled tirzepatide groups versus glargine was 0.74 (95% CI 0.511.08), suggesting no increased cardiovascular risk with tirzepatide compared to insulin glargine
Many clients use both, and IV for the cellular foundation, topical for surface protection